Atlas Trials

Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response

Clinical trial NCT04278547 · UNKNOWN

Trial details

NCT number
NCT04278547
Sponsor
Hospital Universitari de Bellvitge
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Transplant InfectionCMV Infection
Start date
2020-06-12
Primary completion
2022-03-25
Enrollment
188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.